NCT03771443

Brief Summary

Celiac disease (CD) is the most common genetically based food intolerance in the world, with a prevalence among approximately 1% of the general population (Guandalini \& Assiri, 2014). CD is a frequent disorder among Egyptian children, both in the general population and in at-risk groups(Abu-Zekry et al., 2008). It is estimated that the incidence of CD is 3 to13 cases per1000, with a higher prevalence among first-degree relatives of patients with CD.Lifelong adherence to a strict gluten free diet (GFD) remains the only available treatment for patients with CD and typically results in a complete return to health. Nevertheless, gluten is not found only in diet, Gluten is commonly used as a binder in products like medication, cosmetics, oral and skin care, and even children's toys. Gluten is found also in toothpastes and other oral health products and it can be swallowed by mistake and initiate immune response(Anon, n.d.). Unfortunately, there is no gluten free toothpaste available in the Egyptian market and it is very expensive if we bought it from Europe or USA. The tube will cost nearly 10 dolars .As a result, the production and availability of gluten free toothpaste in Egypt has become mandatory.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jul 2019

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2018

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 11, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

July 21, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 21, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 21, 2020

Completed
Last Updated

July 21, 2020

Status Verified

July 1, 2020

Enrollment Period

6 months

First QC Date

December 8, 2018

Last Update Submit

July 18, 2020

Conditions

Keywords

Gluten-free toothpaste,celiac disease, GFD, children

Outcome Measures

Primary Outcomes (1)

  • Ulcerative events

    Reporting from the parent (Yes or No)

    Six months

Secondary Outcomes (1)

  • Inflammation or ulceration

    six months

Study Arms (1)

gluten free toothpaste

EXPERIMENTAL

experimental gluten free toothpaste with natural ingredients prepared for the study to be used 3 times per day for six months

Drug: experimental gluten free toothpaste

Interventions

we prepared gluten free toothpaste in the faculty of pharmacy -Cairo university because there is no gluten free toothpaste available in the Egyptian market .

Also known as: natural toothpaste
gluten free toothpaste

Eligibility Criteria

Age6 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age above 6 yeas.
  • Erupting lower 6.
  • Can spit the toothpaste.
  • Diagnosed as a celiac patient(pathology\&serology)

You may not qualify if:

  • With a history of allergy to any ingredient present in the toothpaste to be used for treatment
  • The presence of serious medical conditions or a transmissible disease such as malignant disease, hepatitis, AIDS etc.
  • Children whose parents had no home or mobile phone to enable post-operative contact.
  • Parent that will not sign the consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Dentistry, Cairo University

Giza, Al Manial, Cairo, Egypt, 11562, Egypt

Location

MeSH Terms

Conditions

Celiac DiseaseJones syndrome

Interventions

green tea bioflavonoid, zinc ascorbate-containing toothpaste

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Eman A Abdelhameed, BSc

    Resident at Pediatric Dentistry and Dental Public Health Department

    PRINCIPAL INVESTIGATOR
  • Fatma KI Abdelgawad, PhD

    Assistant Professor at Pediatric Dentistry and Dental Public Health Department

    STUDY CHAIR
  • Kamal M El Motayam, PhD

    Emeritus Professor at Pediatric Dentistry and Dental Public Health Department

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
master degree student

Study Record Dates

First Submitted

December 8, 2018

First Posted

December 11, 2018

Study Start

July 21, 2019

Primary Completion

January 21, 2020

Study Completion

January 21, 2020

Last Updated

July 21, 2020

Record last verified: 2020-07

Locations